日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Aminomethyl Spectinomycins as Therapeutics for Drug-Resistant Gonorrhea and Chlamydia Coinfections.

氨甲基壮观霉素作为治疗耐药性淋病和衣原体合并感染的药物

Butler Michelle M, Waidyarachchi Samanthi L, Connolly Kristie L, Jerse Ann E, Chai Weirui, Lee Richard E, Kohlhoff Stephan A, Shinabarger Dean L, Bowlin Terry L

Preclinical development of Ramizol, an antibiotic belonging to a new class, for the treatment of Clostridium difficile colitis.

Ramizol 是一种新型抗生素,用于治疗艰难梭菌结肠炎,目前正处于临床前开发阶段

Rao Shasha, Prestidge Clive A, Miesel Lynn, Sweeney Deb, Shinabarger Dean L, Boulos Ramiz A

Tricyclic GyrB/ParE (TriBE) inhibitors: a new class of broad-spectrum dual-targeting antibacterial agents

三环GyrB/ParE (TriBE)抑制剂:一类新型广谱双靶点抗菌剂

Tari, Leslie W; Li, Xiaoming; Trzoss, Michael; Bensen, Daniel C; Chen, Zhiyong; Lam, Thanh; Zhang, Junhu; Lee, Suk Joong; Hough, Grayson; Phillipson, Doug; Akers-Rodriguez, Suzanne; Cunningham, Mark L; Kwan, Bryan P; Nelson, Kirk J; Castellano, Amanda; Locke, Jeff B; Brown-Driver, Vickie; Murphy, Timothy M; Ong, Voon S; Pillar, Chris M; Shinabarger, Dean L; Nix, Jay; Lightstone, Felice C; Wong, Sergio E; Nguyen, Toan B; Shaw, Karen J; Finn, John